Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Subcutaneous implantation of estradiol pellets for postmenopausal disorders. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2010 Authors' objectives <p>Menopause, the cessation of menstruation, occurs at around age 50 years for most women. During this process, levels of the hormone estrogen fall dramatically and women may experience hot flashes, sleep disorders, mood swings, vaginal dryness, and decreased sexual desire. In addition, osteoporosis can occur if estrogen levels remain low for prolonged periods. These symptoms can be reduced or prevented by use of hormone replacement therapy (HRT), which typically involves administration of estrogen and progesterone via pills, skin patches, or gels.</p> Timeliness warning This report has been archived and may contain outdated information. To request a copy of the report please contact the organisation directly. Indexing Status Subject indexing assigned by CRD MeSH Estrogen Replacement Therapy; Estrogens; Females; Postmenopause; Prostheses and Implants; Subcutaneous Tissue Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32011000851 Date abstract record published 22/06/2011 |